Search research articles
Contact Us
Filters
Showing results (71-80 of 127) with videos related to
Page
of 13
Sort By:
Expert Opinion on Pharmacotherapy
|
January 29, 2024
Effectively addressing cardiovascular risk in people with metabolic-dysfunction associated fatty liver disease: not yet ready for prime time!
Theocharis Koufakis, Djordje S Popovic, Christodoulos Papadopoulos, et al.
The American Journal of Cardiology
|
September 7, 2020
Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus
Dimitrios Patoulias, Christodoulos Papadopoulos, Alexandra Katsimardou, et al.
Current Vascular Pharmacology
|
April 10, 2019
Pharmacological Management of Diabetic Nephropathy
Vasilios Papademetriou, Sofia Alataki, Konstantinos Stavropoulos, et al.
Journal of Cardiovascular Development and Disease
|
June 25, 2026
Prognostic Value of Right Ventricular Performance and Left Atrial Mechanical Efficiency in Paroxysmal Atrial Fibrillation
Aristi Boulmpou, Efstathios Pagourelias, Georgios Zormpas, et al.
Medicina (Kaunas, Lithuania)
|
September 23, 2022
Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study
Dimitrios Patoulias, Christodoulos Papadopoulos, Ioanna Zografou, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 15, 2020
Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors
Dimitrios Patoulias, Christodoulos Papadopoulos, Konstantinos Stavropoulos, et al.
The American Journal of Cardiology
|
November 19, 2021
Updated Meta-Analysis Evaluating the Beneficial Effects of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure
Dimitrios Patoulias, Christodoulos Papadopoulos, George Kassimis, et al.
The American Journal of Cardiology
|
November 19, 2021
Meta-Analysis of Dedicated Heart Failure Trials Evaluating the Effect of Sacubitril/Valsartan on Major Cardiac Rhythm Disorders
Dimitrios Patoulias, Christodoulos Papadopoulos, Maria Toumpourleka, et al.
The American Journal of Cardiology
|
December 3, 2021
Meta-Analysis Addressing the Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Flow-Mediated Dilation in Patients With Type 2 Diabetes Mellitus
Dimitrios Patoulias, Christodoulos Papadopoulos, George Kassimis, et al.
Current Pharmaceutical Design
|
March 12, 2019
Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
Konstantinos Stavropoulos, Christodoulos Papadopoulos, Konstantinos Koutsampasopoulos, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 127) with videos related to
Sort By:
Page
of 13
Expert Opinion on Pharmacotherapy
|
January 29, 2024
Effectively addressing cardiovascular risk in people with metabolic-dysfunction associated fatty liver disease: not yet ready for prime time!
Theocharis Koufakis, Djordje S Popovic, Christodoulos Papadopoulos, et al.
The American Journal of Cardiology
|
September 7, 2020
Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus
Dimitrios Patoulias, Christodoulos Papadopoulos, Alexandra Katsimardou, et al.
Current Vascular Pharmacology
|
April 10, 2019
Pharmacological Management of Diabetic Nephropathy
Vasilios Papademetriou, Sofia Alataki, Konstantinos Stavropoulos, et al.
Journal of Cardiovascular Development and Disease
|
June 25, 2026
Prognostic Value of Right Ventricular Performance and Left Atrial Mechanical Efficiency in Paroxysmal Atrial Fibrillation
Aristi Boulmpou, Efstathios Pagourelias, Georgios Zormpas, et al.
Medicina (Kaunas, Lithuania)
|
September 23, 2022
Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study
Dimitrios Patoulias, Christodoulos Papadopoulos, Ioanna Zografou, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 15, 2020
Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors
Dimitrios Patoulias, Christodoulos Papadopoulos, Konstantinos Stavropoulos, et al.
The American Journal of Cardiology
|
November 19, 2021
Updated Meta-Analysis Evaluating the Beneficial Effects of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure
Dimitrios Patoulias, Christodoulos Papadopoulos, George Kassimis, et al.
The American Journal of Cardiology
|
November 19, 2021
Meta-Analysis of Dedicated Heart Failure Trials Evaluating the Effect of Sacubitril/Valsartan on Major Cardiac Rhythm Disorders
Dimitrios Patoulias, Christodoulos Papadopoulos, Maria Toumpourleka, et al.
The American Journal of Cardiology
|
December 3, 2021
Meta-Analysis Addressing the Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Flow-Mediated Dilation in Patients With Type 2 Diabetes Mellitus
Dimitrios Patoulias, Christodoulos Papadopoulos, George Kassimis, et al.
Current Pharmaceutical Design
|
March 12, 2019
Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
Konstantinos Stavropoulos, Christodoulos Papadopoulos, Konstantinos Koutsampasopoulos, et al.
Page
of 13